ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,018.39
-0.34%
US Tech 100
17,008.40
0.88%
다우존스 지수
37,903.29
0.23%
Bitcoin
57,860.16
-0.65%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. BioCryst Pharmaceuticals Inc (BCRX)

  7. BioCryst Pharmaceuticals Inc (BCRX) 뉴스

BCRX BioCryst Pharmaceuticals Inc

4.57
0.00 (0.00%)
시간외 단일가
최종 업데이트: 17:01:28
15분 지연
기업명 주식 심볼 시장 주식 타입
BioCryst Pharmaceuticals Inc BCRX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 4.57 17:01:28
개장가 저가 고가 종가 전일 종가
4.57
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
22/04/202420:00GLOBEBioCryst to Report First Quarter 2024 Financial Results on..
17/04/202417:30GLOBEBioCryst Announces Approval of ORLADEYO® (berotralstat) by..
03/04/202420:00GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
26/03/202405:01GLOBEBioCryst to Present at Upcoming Investor Conferences
05/03/202421:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
05/03/202407:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202406:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202407:05EDGAR2Form S-3ASR - Automatic shelf registration statement of..
26/02/202421:05EDGAR2Form 8-K - Current report
26/02/202421:00GLOBEBioCryst Reports Fourth Quarter and Full Year 2023 Financial..
26/02/202419:57IHMARKETNEWSU.S. Index Futures Dip Amid Inflation Data Anticipation, Oil..
23/02/202421:00GLOBEBioCryst Presents New Real-world Data Showing Rapid,..
22/02/202406:01GLOBEBioCryst to Present at Upcoming Investor Conferences
19/02/202421:54GLOBEBioCryst Launches ORLADEYO® (berotralstat) in Italy
15/02/202406:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202423:02EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/02/202421:00GLOBEBioCryst to Report Fourth Quarter 2023 Financial Results on..
05/02/202421:00GLOBEBioCryst to Present New ORLADEYO® (berotralstat) Real-world..
02/02/202421:00GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
25/01/202407:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/01/202407:21EDGAR2Form 8-K - Current report
08/01/202421:02EDGAR2Form 8-K - Current report
06/01/202406:01GLOBEBioCryst Announces Preliminary Full Year 2023 ORLADEYO®..
05/01/202406:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
03/01/202421:00GLOBEBioCryst to Present at 42nd Annual J.P. Morgan Healthcare..
21/12/202306:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202306:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202306:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202306:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202306:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202321:00GLOBEBioCryst Announces Publication of Data from Open-label..
19/12/202306:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202306:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202306:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202306:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202306:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202306:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
02/12/202306:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202306:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202321:37EDGAR2Form 8-K - Current report
30/11/202323:04EDGAR2Form 8-K - Current report
29/11/202321:00GLOBEBioCryst Announces Approval of ORLADEYO® (berotralstat) by..
22/11/202306:01GLOBEBioCryst to Present at Upcoming Investor Conferences
21/11/202321:00GLOBEBioCryst Launches ORLADEYO® (berotralstat) in Spain
10/11/202321:00GLOBEBioCryst Presents New Real-world Data Showing Reduced Attack..
09/11/202306:29EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/11/202306:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202306:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
04/11/202301:16EDGAR2Form 8-K - Current report

최근 히스토리

NASDAQ
BCRX
BioCryst Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유